Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

Photo of Rubinstein, Israel

Israel Rubinstein, MD

Professor of Medicine

Department of Medicine, Division of Pulmonary, Critical Care, Sleep and Allergy


List Accomplishments/Awards/Honor :

Dr Rubinstein holds several issued and pending US and international patents and has authored more than 200 peer-reviewed scientific papers. He is Editor-in-Chief, Nanotechnology, Science and Applications, Clinical Editor, Nanomedicine: Nanotechnology, Biology and Medicine and Associate Editor, International Journal of Nanomedicine. Dr. Rubinstein co-founded ResQ Pharma, Inc. that has recently submitted an IND application to the US FDA, and EnSol Therapeutics, LLC. Dr. Rubinstein is Board Member and Director of Advanced Life Sciences, a publicly-traded biopharmaceutical company in Woodridge, Illinois, USA.


Medical School: Hebrew University, Jerusalem, Israel
Residency: The Chaim Sheba Medical Center, Tel-Hashomer, Israel
Fellowship: University of Toronto, Toronto, Ontario, Canada